Current Assets Изменить Дата
Acadia Pharmaceuticals USD 499.17M 6.54M 2023-09
Agios Pharmaceuticals USD 704.35M 52.89M 2023-09
Alnylam Pharmaceuticals USD 2.99B 461.4M 2023-09
Amgen USD 48.48B 1.1B 2023-09
Bayer EUR 37.53B 1.25B 2023-09
Biogen USD 8.45B 1.98B 2023-09
BioMarin Pharmaceutical USD 2.96B 5.19M 2023-09
Bluebird Bio USD 247.08M 40.9M 2023-09
Gilead Sciences USD 15.98B 1.69B 2023-09
Incyte USD 4.4B 138.23M 2023-09
Insmed USD 926.58M 125.85M 2023-09
Ionis Pharmaceuticals USD 2.58B 32.1M 2023-09
Moderna USD 10.8B 200M 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
PTC Therapeutics USD 540.36M 49.33M 2023-09
Regeneron Pharmaceuticals USD 18.63B 1.71B 2023-09
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
United Therapeutics USD 3.46B 245.5M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



BioMarin Pharmaceutical Текущие Активы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.